132 related articles for article (PubMed ID: 11708415)
1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
Carbone J; Sánchez-Ramón S; Cobo-Soriano R; Seoane E; Aparicio MJ; Ruiz-Tíscar JL; Rodríguez-Mahou M; Rodríguez-Molina JJ; Sarmiento E; Cortés C; Fernández-Cruz E
J Rheumatol; 2001 Nov; 28(11):2437-41. PubMed ID: 11708415
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study.
Cobo-Soriano R; Sánchez-Ramón S; Aparicio MJ; Teijeiro MA; Vidal P; Suárez-Leoz M; Rodriguez-Mahou M; Rodriguez-Huerta A; Fernández-Cruz E; Cortés C
Am J Ophthalmol; 1999 Dec; 128(6):725-32. PubMed ID: 10612509
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome in patients with retinal venous occlusion.
Paccalin M; Manic H; Bouche G; Landron C; Mercié M; Boinot C; Gombert JM; Roblot P; Dighiero P
Thromb Res; 2006; 117(4):365-9. PubMed ID: 16461072
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies in ocular arterial and venous occlusive disease.
Palmowski-Wolfe AM; Denninger E; Geisel J; Pindur G; Ruprecht KW
Ophthalmologica; 2007; 221(1):41-6. PubMed ID: 17183200
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients.
Glacet-Bernard A; Bayani N; Chretien P; Cochard C; Lelong F; Coscas G
Arch Ophthalmol; 1994 Jun; 112(6):790-5. PubMed ID: 8002838
[TBL] [Abstract][Full Text] [Related]
8. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
9. [Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases].
Ermakova NA; Alekberova ZS; Nasonov EL; Kosheleva NM; Reshetniak TM; Aleksandrova EN
Vestn Oftalmol; 2002; 118(2):29-32. PubMed ID: 12096532
[TBL] [Abstract][Full Text] [Related]
10. [Anticardiolipin antibodies in vascular occlusions of the eye].
Bertram B; Haase G; Remky A; Reim M
Ophthalmologe; 1994 Dec; 91(6):768-71. PubMed ID: 7849429
[TBL] [Abstract][Full Text] [Related]
11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
12. [Retinal vasculitis and antiphospholipid antibodies].
Zierhut M; Klein R; Berg P; Türmer KH; Raphael B
Ophthalmologe; 1994 Dec; 91(6):772-6. PubMed ID: 7849430
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
14. Role of hyperhomocystinemia in retinal vascular occlusive disease.
Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammi C; Occhiuto A; Lombardo VT
Clin Appl Thromb Hemost; 2007 Jan; 13(1):104-7. PubMed ID: 17164500
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
[TBL] [Abstract][Full Text] [Related]
17. [Retinal thrombosis in young patients. Immunological and clinical aspects].
Cobo Soriano R; Aparicio Hernández-Lastras MJ; Seoane E; Sánchez-Ramón S; Vidal Fernández P; Teijeiro Permuy MA; Carboné J; Suárez Leoz M
Arch Soc Esp Oftalmol; 2001 Mar; 76(3):181-8. PubMed ID: 11283785
[TBL] [Abstract][Full Text] [Related]
18. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
[TBL] [Abstract][Full Text] [Related]
19. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
Kisiel E; Kryczka W
Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of stroke patients with antiphospholipid antibodies.
Terashi H; Uchiyama S; Hashimoto S; Miyazaki K; Tsutsumi Y; Yamazaki M; Iwata M
Cerebrovasc Dis; 2005; 19(6):384-90. PubMed ID: 15863981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
